<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: To evaluate the prevalence of thrombophilic risk factors known to induce intravascular clotting and to assess their relationship with ischemic manifestations in giant cell <z:hpo ids='HP_0012089'>arteritis</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GCA</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Eighty consecutive patients with established <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GCA</z:e> were included: 36 with isolated temporal <z:hpo ids='HP_0012089'>arteritis</z:hpo> (TA), 14 with isolated <z:e sem="disease" ids="C0032533" disease_type="Disease or Syndrome" abbrv="pmr">polymyalgia rheumatica</z:e> (PMR), and 30 with TA and PMR </plain></SENT>
<SENT sid="2" pm="."><plain>Forty-four patients (67%) had ischemic phenomena due to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GCA</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Twelve patients (15%) had thrombotic events unrelated to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GCA</z:e> (6 <z:hpo ids='HP_0001297'>strokes</z:hpo>, 5 <z:hpo ids='HP_0002625'>deep venous thrombosis</z:hpo>, and 1 <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo>) </plain></SENT>
<SENT sid="4" pm="."><plain>A control group of 100 age- and sex-matched individuals without <z:hpo ids='HP_0002960'>autoimmune disease</z:hpo>, <z:mp ids='MP_0001914'>bleeding</z:mp> disorders, <z:mp ids='MP_0005048'>thrombosis</z:mp>, or clinical picture of TA or PMR also was analyzed </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> participants were tested for the <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> (aPL) profile, protein C, protein S, antithrombin activity, <z:e sem="disease" ids="C0584960" disease_type="Disease or Syndrome" abbrv="">factor V Leiden mutation</z:e>, and prothrombin gene G20210A mutation </plain></SENT>
<SENT sid="6" pm="."><plain>We also studied fibrinolysis parameters: plasminogen, tissue-type plasminogen activator (t-PA) antigen, t-PA activity, type-1 plasminogen activator inhibitor (PAI-1) antigen, PAI-1 activity, and the 4G/5G polymorphism of the promoter region of the PAI-1 gene </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: Eleven patients (18%) tested positive for <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi>, 24 (30%) for anticardiolipin antibodies, 9 (11%) for anti-beta 2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I antibodies, and 29 (36%) for antiprothrombin antibodies </plain></SENT>
<SENT sid="8" pm="."><plain>No relationship was found between these autoantibodies and ischemic manifestations </plain></SENT>
<SENT sid="9" pm="."><plain>None of the patients had decreased protein C, protein S or antithrombin activity </plain></SENT>
<SENT sid="10" pm="."><plain>Two patients and 2 controls were heterozygous for factor V Leiden, and only 1 patient and 2 controls were heterozygous for the prothrombin gene G20210A mutation </plain></SENT>
<SENT sid="11" pm="."><plain>No statistically significant correlation was found between any thrombophilic factor and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GCA</z:e>-related or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GCA</z:e>-unrelated ischemic events </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSION: <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GCA</z:e> patients have a high prevalence of aPL that is not related to ischemic manifestations </plain></SENT>
<SENT sid="13" pm="."><plain>Moreover, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GCA</z:e>-related or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GCA</z:e>-unrelated ischemic manifestations do not appear to be due to congenital thrombophilic risk factors </plain></SENT>
<SENT sid="14" pm="."><plain>Semin <z:hpo ids='HP_0001369'>Arthritis</z:hpo> Rheum 31:12-20 </plain></SENT>
</text></document>